Presenting authors can submit one abstract only but can be co-authors of other abstracts.

• Maximum character limit: 2500
• Languages of submission: English
• Title Format: Abstract titles are limited to 120 characters or less. The title should be dynamic and conclusive, rather than descriptive, and should be entered in a title case format. In general, you should capitalize only the first letter of each word unless it is a preposition or article.
• Content Format: Objective, Methods, Results and Conclusion.
• Supplemental figures/tables/references are not permitted.
• Abstracts being submitted must be original research. Any abstract violating copyright laws and/or including plagiarized content will be rejected.
• Submitters may not split one study into several papers.

Authors will be invited to specify their preferred presentation type. The scientific committee will assign the final presentation type.

1. Oral communication

Selected oral presentations will be organized around central subspecialties or topics in various sessions. Presenters will be allocated 7 minutes presentation time and 3 minutes for Q&A.

2. Poster

Top-scored posters will be selected for a Poster Pod Presentation. If selected for a poster presentation, the author will be required to prepare a 5-minute PowerPoint presentation in addition to their printed poster. The PowerPoint presentation will have to be uploaded via the Speaker Ready Room onsite.

Printed poster of the latest research results in the field of study displayed in the Exhibition Hall. Instructions to prepare the printed poster will be shared with the notification of acceptance mid-March.

3. Videos

Videos are short films of one to five minutes in length. Videos can include presentations of a new examination, investigation, or technique or presentation of an interesting case and how it was managed. Video presenters will be required to use the same Video that was accepted.

• Advances in Vision Sciences
• Artificial Intelligence & Ocular Imaging
• Cataract and Refractive Surgery
• Cornea
• Glaucoma
• International Eye Care
• Myopia
• Neuro-ophthalmology

• Ocular Oncology
• Ocular Trauma
• Ophthalmic Pathology
• Orbital, Oculoplastic, and Lacrimal Diseases
• Pediatric Ophthalmology and Strabismus
• Retina and Uveitis
• Vision Rehabilitation
• Young Ophthalmologists

Presenter agreement

All presenting authors must agree to the following conditions when submitting an abstract:

1. Any work with human or animal subjects reported in the abstract complies with the guiding principles for experimental procedures found in the Declaration of Helsinki of the World Medical Association, and this research project has been duly cleared by my Institutional Review Board (IRB) or the ICO Ethics Committee.

2. If the abstract is accepted, the ICO has permission to publish the abstract in printed and/or electronic formats.

3. Register for the meeting and pay the appropriate registration fee by the presenter registration deadline of 9 April 2026.

4. By submitting an abstract to the ICO, and in consideration for the opportunity to be included in the WOC presentations, the author(s) of the abstract hereby provides to the ICO a non-exclusive, irrevocable, worldwide, royalty-free license to use the abstract in the ICO’s electronic mediums and printed materials.

5. The author(s) grants the permission to reproduce his/her image (including photos) to create documentation to be published on the internet (including streaming) and to make the audio/video recording (synchro recording system), and photographs of the presentation to produce educational materials. The presentation will be reproduced in full compliance with its contents both in terms of scientific results and information, associated with the image and the data of the undersigned.

Acceptance notification

All abstracts received by the indicated deadline will be evaluated by the Scientific Program Committee. Acceptance will be notified to the submitting author by 17 December 2025.